Clinical trial
Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or…
NCT00475215 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00475215 |
|---|---|
| Title | Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017) |
| Official title | A Multicenter, Randomized, Parallel Group, Comparative, Safety-Assessor Blinded, Phase IIIa Trial in Adult Surgical Subjects Under General Anesthesia at Increased Risk for Pulmonary Complications |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anesthesia, General |
| Intervention type | Drug |
| Interventions | Sugammadex, Rocuronium |
| Enrollment | 86 |
| Start date | Oct 27, 2005 |
| Primary completion | Aug 21, 2006 |
| Completion | Sep 9, 2006 |
| First posted | May 21, 2007 |
| Last update posted | Apr 12, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: